Basic Responsive HTML5
  • Hiring
  • About
    • Corporate Overview
    • Founder
    • Management
    • Scientific Advisory Board
    • Board of Directors
    • Board of Advisors
    • Partnerships
    • Contact
  • Videos
    • CEO Updates
    • News
    • Patient Testimonials
  • Technology
    • Technology Overview
    • Manufacturing
    • Intellectual Property
    • Publications
  • Clinical Pipeline
    • ACP-01 Phase II Clinical Trial for CLI
    • Platform
    • Critical Limb Ischemia
  • News & Media
    • News / Press Releases
    • Blog
  • Investor
    • Investor Presentations
    • A Three Minute Summary
    • Analysts
    • Public Filings
    • AGM Materials
MENU ≡
  • Hiring
  • About
    • Corporate Overview
    • Founder
    • Management
    • Scientific Advisory Board
    • Board of Directors
    • Board of Advisors
    • Partnerships
    • Contact
  • Videos
    • CEO Updates
    • News
    • Patient Testimonials
  • Technology
    • Technology Overview
    • Manufacturing
    • Intellectual Property
    • Publications
  • Clinical Pipeline
    • ACP-01 Phase II Clinical Trial for CLI
    • Platform
    • Critical Limb Ischemia
  • News & Media
    • News / Press Releases
    • Blog
  • Investor
    • Investor Presentations
    • A Three Minute Summary
    • Analysts
    • Public Filings
    • AGM Materials

Blog

Tweets by Hemostemix_Inc
  • Hemostemix’ “Your Fountain of Youth” Trademark Granted by Japan Patent Office
  • Hemostemix Wins Arbitration Decision
  • Hemostemix Hiring 4 New Biotechnologists in Montreal and Applying for Grants to Fund up to 75% of 5-Year Costs
  • Hemostemix Announces Letter of Commitment, Non-dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation
  • Hemostemix Issued “Your Fountain of Youth” Trademark by Cyprus

  • Contact
  • Safe Harbour

Copyright © 2023 Hemostemix Inc. All rights reserved.